DE2506355C2 - Aryloxyaminobutanole, deren nicht toxische Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate - Google Patents

Aryloxyaminobutanole, deren nicht toxische Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate

Info

Publication number
DE2506355C2
DE2506355C2 DE2506355A DE2506355A DE2506355C2 DE 2506355 C2 DE2506355 C2 DE 2506355C2 DE 2506355 A DE2506355 A DE 2506355A DE 2506355 A DE2506355 A DE 2506355A DE 2506355 C2 DE2506355 C2 DE 2506355C2
Authority
DE
Germany
Prior art keywords
compounds
hydroxy
butane
general formula
naphthyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2506355A
Other languages
German (de)
English (en)
Other versions
DE2506355A1 (de
Inventor
Kalman Dr. Harsanyi
Deszoe Dr. Budapest Korbonits
Geb. Bako Erzsebet Dr. Szoedliget Molnar
Jozsef Dr. Debrecen Szegi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1045 Budapest Hu
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1045 Budapest Hu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1045 Budapest Hu filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1045 Budapest Hu
Publication of DE2506355A1 publication Critical patent/DE2506355A1/de
Application granted granted Critical
Publication of DE2506355C2 publication Critical patent/DE2506355C2/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2506355A 1974-02-20 1975-02-14 Aryloxyaminobutanole, deren nicht toxische Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate Expired DE2506355C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1449A HU169464B (US06649357-20031118-C00005.png) 1974-02-20 1974-02-20

Publications (2)

Publication Number Publication Date
DE2506355A1 DE2506355A1 (de) 1975-08-21
DE2506355C2 true DE2506355C2 (de) 1983-10-06

Family

ID=10994508

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2506355A Expired DE2506355C2 (de) 1974-02-20 1975-02-14 Aryloxyaminobutanole, deren nicht toxische Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate

Country Status (22)

Country Link
JP (1) JPS5929063B2 (US06649357-20031118-C00005.png)
AT (1) AT339281B (US06649357-20031118-C00005.png)
BE (1) BE825745A (US06649357-20031118-C00005.png)
BG (2) BG26366A3 (US06649357-20031118-C00005.png)
CA (1) CA1074338A (US06649357-20031118-C00005.png)
CH (1) CH619684A5 (US06649357-20031118-C00005.png)
CS (1) CS199578B2 (US06649357-20031118-C00005.png)
DD (1) DD119414A5 (US06649357-20031118-C00005.png)
DE (1) DE2506355C2 (US06649357-20031118-C00005.png)
DK (1) DK141935B (US06649357-20031118-C00005.png)
ES (2) ES434784A1 (US06649357-20031118-C00005.png)
FI (1) FI61304C (US06649357-20031118-C00005.png)
FR (1) FR2261001B1 (US06649357-20031118-C00005.png)
GB (1) GB1457086A (US06649357-20031118-C00005.png)
HU (1) HU169464B (US06649357-20031118-C00005.png)
IL (1) IL46634A (US06649357-20031118-C00005.png)
NL (1) NL182698C (US06649357-20031118-C00005.png)
NO (1) NO141754C (US06649357-20031118-C00005.png)
PL (2) PL99025B1 (US06649357-20031118-C00005.png)
SE (1) SE433935B (US06649357-20031118-C00005.png)
SU (1) SU1025327A3 (US06649357-20031118-C00005.png)
YU (2) YU36916B (US06649357-20031118-C00005.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48309A (en) * 1974-10-25 1980-01-31 Robins Co Inc A H 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them
EP0097000B1 (en) * 1982-06-10 1987-09-09 Beecham Wuelfing GmbH & Co KG Amine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368197B (US06649357-20031118-C00005.png) * 1968-11-18 1974-06-24 Pfizer
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
AT305245B (de) * 1969-09-24 1973-02-12 Ici Ltd Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen

Also Published As

Publication number Publication date
NL182698C (nl) 1988-05-02
FR2261001B1 (US06649357-20031118-C00005.png) 1978-07-21
CS199578B2 (en) 1980-07-31
HU169464B (US06649357-20031118-C00005.png) 1976-11-28
FI61304C (fi) 1982-07-12
BG26366A3 (bg) 1979-03-15
SE7501801L (US06649357-20031118-C00005.png) 1975-08-21
DE2506355A1 (de) 1975-08-21
JPS50117728A (US06649357-20031118-C00005.png) 1975-09-16
DK60875A (US06649357-20031118-C00005.png) 1975-10-20
DD119414A5 (US06649357-20031118-C00005.png) 1976-04-20
BE825745A (fr) 1975-06-16
JPS5929063B2 (ja) 1984-07-18
IL46634A0 (en) 1975-04-25
ES434784A1 (es) 1977-03-16
DK141935B (da) 1980-07-21
FI750443A (US06649357-20031118-C00005.png) 1975-08-21
NL7501951A (nl) 1975-08-22
ATA114075A (de) 1977-02-15
SU1025327A3 (ru) 1983-06-23
YU37116B (en) 1984-08-31
SE433935B (sv) 1984-06-25
YU36916B (en) 1984-08-31
FI61304B (fi) 1982-03-31
PL99025B1 (pl) 1978-06-30
DK141935C (US06649357-20031118-C00005.png) 1980-12-08
AT339281B (de) 1977-10-10
YU167681A (en) 1983-04-27
BG26367A4 (bg) 1979-03-15
GB1457086A (en) 1976-12-01
NO750566L (US06649357-20031118-C00005.png) 1975-08-21
YU37375A (en) 1982-06-18
PL99023B1 (pl) 1978-06-30
CA1074338A (en) 1980-03-25
ES453326A1 (es) 1977-11-16
CH619684A5 (en) 1980-10-15
NO141754B (no) 1980-01-28
FR2261001A1 (US06649357-20031118-C00005.png) 1975-09-12
NO141754C (no) 1980-05-07
IL46634A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
DE1468092B2 (de) Aminopropoxy-derivate des tetrahydronaphthalins und des indans, deren saeureadditionssalze, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate
DE2143204B2 (de) N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
DE2216537A1 (de) Aminoalkohole,verfahren zu deren herstellung und deren verwendung
DE2506355C2 (de) Aryloxyaminobutanole, deren nicht toxische Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und diese Verbindungen enthaltende pharmazeutische Präparate
DE2044172B2 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
EP0005821B1 (de) Indanaminderivate, Verfahren zur Herstellung derselben und Arzneimittel, welche diese enthalten
DE2225332A1 (de) 1 eckige Klammer auf 4 Hydroxy 3 (hydroxymethyl) phenyl eckige Klammer zu 1 hydroxy 2 aralkylaminoathane
DE1695140A1 (de) Verfahren zur Herstellung von Phenanthridinderivaten
DE2803688A1 (de) Neue benzolsulfonamid- und benzolcarboxamidderivate
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
DE1909408A1 (de) Tricyclische Verbindungen
DE1949987B2 (de) Neue alpha-phenylfettsaeureverbindungen
DE2421165A1 (de) N-substituierte dihydroxyphenylaethylamine
DE2635064C2 (de) Arzneimittel, enthaltend ein 2-(1-Hydroxyäthyl)-benzofuranderivat, 2-(1-Hydroxyäthyl)-benzofuranderivate als solche und Verfahren zu ihrer Herstellung
DE2047937A1 (de) Hydroxyphenyl 2 pipendtnylcarbi nole und ihre Verwendung in Arzneimitteln
DE1468283C (US06649357-20031118-C00005.png)
DE2530768C3 (de) PhenoxyaUcylaminpyridyläther, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DD149664A5 (de) Verfahren zur herstellung von 1,1'-biphenyl-2-yl-alkylamin-derivaten
DE1901175A1 (de) Verfahren zur Herstellung von neuen Piperidinderivaten
DE2123319A1 (de) S-Sulfonamido^-hydroxyphenyl^piperidylcarbinole, Verfahren zu ihrer Herstellung und Arzeneipräparate
DE2201804C3 (de) Phenyläthylbenzylamine und Verfahren zu ihrer Herstellung
AT303025B (de) Verfahren zur herstellung neuer indolderivate und ihrer saeureadditionssalze
DE3027338C2 (de) Isochinolinderivate, ihre Salze, Verfahren zu ihrer Herstellung und therapeutische Zubereitung
AT229292B (de) Verfahren zur Herstellung von neuen basisch substituierten Diphenylalkanderivaten und ihren Salzen
AT340899B (de) Verfahren zur herstellung von neuen 1-aryloxy-2-hydroxy-4-sek.aminobutanen und deren nichttoxischen saureadditionssalzen

Legal Events

Date Code Title Description
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee